PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS). Bertis developed the PASS solution based on its pan-omics, bioinformatics, and artificial intelligence (AI) technologies. We provide a variety of analyzes for proteomic analysis, biomarker discovery and verification, new drug development, clinical process development, etc. PASS is a platform for integrative analysis of pan-omics data, based on our proven and reliable bioinformatics analysis capabilities. Our team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics. Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable. With PASS, you can leverage Bertis scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.
Exo-PASS Exosomes contain proteins, lipids, nucleic acids, and metabolites, and can be easily enriched from biofluids, providing very valuable information for early detection and monitoring of diseases. The Ministry of Food and Drug Safety requires RNA, lipid and proteomic analyses in its guidelines for the development of exosome therapeutics, and PASS provides these analyses in an all-in-one package. Exosome RNA Sequencing: PASS enables rapid and efficient isolation of RNAs and profiling of exosome nucleic acids using qRT-PCR and novel sequencing methods. Exosome Lipidomics: We perform high-reliability and high-sensitivity analysis through an ultra-high-performance tool (UPLC, Orbitrap Exploris 480 MS) and lipid analysis experts who have been producing and interpreting analysis data for many years. Exosome Proteomics: PASS offers and performs quantification analysis that meets customer needs based on the unique expertise in exosome protein extraction. We provide reliable results through deep profiling of exosome proteome and a specialized data library. Our world-class bioinformatics research team at Bertis reviews and interprets pan-omics data (RNA/Lipid) to support in-depth research.
Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood. High diagnostic accuracy : Quantitative values of biomarkers are measured and entered in a unique algorithm with applied AI. Convenience : No burden of inconvenience caused due to the use of a separate diagnostic device other than blood sampling Efficiency: Provides diagnosis opportunities to more people in situations where personnel and devices are limited
MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm. An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood. Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy and reproducibility among these combinations. DEVELOPMENT PROCESS: - MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University. - After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy, the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy. - After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.
Easy-to-use "All-in-one" test for the detection of anti SARS-CoV-2 antibodies (lgM & lgG) The Novel Coronavirus 2019-nCoV) lgM/lgG Antibody Combo Test Kit (Colloidal Gold) is intended for the qualitative detection of the antibodies of lgM/lgG against novel coronavirus in serum, plasma, or whole blood from patients with clinical suspicion of 2019-nCoV infection
Rapid Test Kit BinaxNOW Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 10 Tests CLIA Waived UOM: 10/KT Product Number: 430100 Manufacturer: Abbott
COVID finger prick, rapid antigen test, or rapid test, is a rapid diagnostic test suitable for point-of-care testing that directly detects the presence or absence of an antigen. It is commonly used for the detection of SARS-CoV-2, the virus that causes COVID-19. Rapid tests are a type of lateral flow tests that detect protein, distinguishing it from other medical tests that detect antibodies or nucleic acid, of either laboratory or point-of-care types. Rapid tests generally give a result in 1 to 15 minutes, require minimal training or infrastructure, and have significant cost advantages. NO Lab Required for results.
Product Description - SARS-CoV-2 Antigen Rapid Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet Covid-19 clinical criteria. Product origin - Turkey / Istanbul Key Specifications/Special Features - vitro diagnostic , Rapid Antigen Test Kit, SARS-CoV-2, Covid 19 Minimum Order Size and Packaging details - 500
FDA EUA
Antigen Rapid Tests for COVID-19 1. mLab mscreen Corona Antigen Test - Simple nasal swap or nasopharyngeal swab / 2. Laihe Novel - Nasopharyngeal swab / 3. Nal von minden dedico plus - Simple nasal swap or nasopharyngeal swab / 4. Joysbio Saliva Rapid Test Kit - Saliva Test Kit CE IVD certified, in stock in Germany, min. 10000 pcs, from EUR 4.99, free delivery within Germany
Laihe / Novel Corona Antigen Test Nasopharyngeal swab / under 30 minutes / Sensitivity 95.07% / CE marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute and IVD / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Nal von minden / dedico plus Simple nasal swap or nasopharyngeal swab / under 30 minutes / Sensitivity 97.10% / TCID50 75.5 / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
mLab / m-screen Corona Antigen Test Simple nasal swap* or nasopharyngeal swab** / Under 30 minutes / Sensitivity 98.32%** and 97.25%* / TCID50 115 / In stock in Germany / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / German Manufacturer / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
COVID-19 Rapid Antigen Self-Test Kit Indiaâ??s first COVID-19 test kit for self-use. Get your test results within 15 min from the comfort of your home & Office. So, there might be a time when you think you have contracted COVID-19 but cannot book a slot for an RT-PCR test. You might be asked to wait a couple of days. In such a circumstance, you can avail of a home/office corona testing� kit� such as Mylab CoviSelf COVID-19 Rapid� Antigen Test for COVID.� It is Indiaâ??s first COVID-19 home test kit to have earned the approval of the ICMR. Anyone above the age of 18 can use it at home. However, adult supervision is suggested if the test kit is used by people below 18. Intelligently Designed Filled with a solution that inactivates the virus and is designed in a manner to control & contain biohazard.
- Product: Covid19 self test kit - Origin: Korea - Payment: CIF, FOB
Product Details: Brand J.Mithra Test Kit Type HBsAg Test Kit (Rapid) Detects All the 11 subtype of HBsAg Sensitivity 100% by WHO Evaluation Specificity 100% by PATH USA Evaluation Cat. No HB010100 Intended Use : Hepacard is visual, rapid, sensitive and accurate one step immunoassay for the qualitative detection of Hepatitis B surface antigen (HBsAg) in Human serum or plasma.The assay is intended to be used as an aid in the recognition and diagnosis of acute infections and chronic infectious carriers of the Hepatitis B Virus(HBV). Salient Features: Detects all the 11 subtype of HBsAg. Antigen Sensitivity- 0.5 ng/ml. No sample preparation required. See through Device for easy result interpretation. Shelf life-30 months at 2-30C. WHO Evaluated with 100% Sensitivity. Evaluations: PATH USA: Sensitivity 100% and Specificity 100% . DEPT. OF CLINICAL VIROLOGY, CMC VELLORE: Sensitivity 100% and Specificity 100% Approved By Drug Controller General Of India( DCGI) For use In Blood Banks.
For the newly discovered new coronavirus mutant strain Omicron(B.1.1.529),our conducts the sequence comparison analysis of its 32 mutation sites. All mutation sites are outside the epitope region recognized by the new crown paired monoclonal antibody selected by our company.Therefore,according to known academic opinions,the effective production strain for Omicron(B.1.1.529)can still be detected by our product"SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immunochromatography)" Next,our will continue to follow up on the mutation of Covid-19perform sequence alignment analysis in timeand evaluate and verify the detection ability of key mutation sites to ensure the sensitivity and specificity of the kit.
Green Spring Box size: 400 pieces in a box (individual packaging) Size: 70.3*44.9*32.4cm Weight: 15.5kg TGA certification
Box size: 400 pieces in a box (individual packaging) Size: 70.3*44.9*32.4cm Weight: 15.5kg TGA certification
HbsAg RAPID TEST KIT
